Literature DB >> 23533085

Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue.

Min Pan1, Fa Tao Li, Yan Li, Fu Man Jiang, Dong Zhi Li, Tze Kin Lau, Can Liao.   

Abstract

Uniparental disomy (UPD) is an uncommon chromosome condition, but UPD involving chromosome 21 is rarely reported. We reported here a case who had first trimester screening test for Down syndrome, chorionic villus sampling for fetal karyotyping, quantitative fluorescence polymerase chain reaction (QF-PCR), as well as non-invasive prenatal testing (NIPT) by maternal plasma sequencing. There were discordant results between fetal karyotyping and NIPT due to UPD 21combined with confined placental mosaicism of trisomy 21. This demonstrated that it is possible to detect placental mosaicism by NIPT, but further studies are required to confirm its sensitivity. Therefore, all positive NIPT results must be confirmed by conventional invasive test and karyotyping. QF-PCR has the additional benefit in diagnosing UPD.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23533085     DOI: 10.1002/pd.4069

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  22 in total

1.  Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.

Authors:  Baran Bayindir; Luc Dehaspe; Nathalie Brison; Paul Brady; Simon Ardui; Molka Kammoun; Lars Van der Veken; Klaske Lichtenbelt; Kris Van den Bogaert; Jeroen Van Houdt; Hilde Peeters; Hilde Van Esch; Thomy de Ravel; Eric Legius; Koen Devriendt; Joris R Vermeesch
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

2.  Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?

Authors:  Caroline Silcock; Lih-Mei Liao; Melissa Hill; Lyn S Chitty
Journal:  Health Expect       Date:  2014-02-20       Impact factor: 3.377

Review 3.  Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.

Authors:  E S Taglauer; L Wilkins-Haug; D W Bianchi
Journal:  Placenta       Date:  2013-12-01       Impact factor: 3.481

4.  Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations.

Authors:  David A Zeevi; Gheona Altarescu; Ariella Weinberg-Shukron; Fouad Zahdeh; Tama Dinur; Gaya Chicco; Yair Herskovitz; Paul Renbaum; Deborah Elstein; Ephrat Levy-Lahad; Arndt Rolfs; Ari Zimran
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

Review 5.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

Review 6.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 7.  Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA.

Authors:  Lyn S Chitty; Y M Dennis Lo
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

8.  Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center.

Authors:  Whitney A Neufeld-Kaiser; Edith Y Cheng; Yajuan J Liu
Journal:  BMC Med       Date:  2015-06-02       Impact factor: 8.775

9.  Distal 10q trisomy with copy number gain in chromosome region 10q23.1-10q25.1: the Wnt signaling pathway is the most pertinent to the gene content in the region of copy number gain: a case report.

Authors:  Siew-Lee Wong; Hsin-Hsu Chou; Chung-Nun Chao; Joseph Hang Leung; Yu-Hsin Chen; Cheng-Da Hsu
Journal:  BMC Res Notes       Date:  2015-06-19

Review 10.  Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects.

Authors:  Peter Benn
Journal:  J Clin Med       Date:  2014-05-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.